Neonatal Alloimmune Neutropenia | Zendy

Leendert Porcelijn | Zendy; Masja de Haas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neonatal Alloimmune Neutropenia

Author(s) -

Leendert Porcelijn,

Masja de Haas

Publication year - 2018

Publication title -

transfusion medicine and hemotherapy

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.971

H-Index - 39

eISSN - 1660-3818

pISSN - 1660-3796

DOI - 10.1159/000492949

Subject(s) - medicine , neutropenia , meningitis , neonatal alloimmune thrombocytopenia , pneumonia , immunology , sepsis , antibiotics , neonatal sepsis , incidence (geometry) , neonatal infection , fetus , leukopenia , pregnancy , pediatrics , biology , chemotherapy , microbiology and biotechnology , physics , optics , genetics

Neonatal alloimmune neutropenia (NAIN, NAIN or NIN) is a neutrophil blood group antagonism, analogous to hemolytic disease of the fetus and newborn (HDFN) and fetal/neonatal alloimmune thrombocytopenia (FNAIT). A limited number of prospective screening studies showed that granulocyte-specific antibodies were detectable in 0.35-1.1% of random postnatal maternal samples and that the incidence of NAIN was below 0.1%. Symptoms vary from none to mild skin infections, omphalitis or more severe infections like pneumonia, sepsis, and meningitis. Treatment of neonatal infection with antibiotics and granulocyte-colony stimulating factor is advised.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research